Slide CordenPharma scientist in lab coat holding binder for News & Press header with white global connectivity background

NEWS & PRESS


All News & Press

June 14, 2022

Corden Connect Editorial: Continuous Improvement of Project Management Organization

Edition 2 / June 2022
Editorial > The Future of CordenPharma Project & Program Management
June 14, 2022

Corden Connect Interviews Managing Director Martin Walde of CordenPharma Lisbon

Edition 2 / June 2022
New Facility Acquisition Video Series > Part 2: Interview with Managing Director Martin Walde
of CordenPharma Lisbon
June 14, 2022

CordenPharma & Wacker Prepare for mRNA Vaccine Production

Edition 2 / June 2022
News > CordenPharma & Wacker Awarded Pandemic Preparedness Contract
June 14, 2022

Fribourg Site Inaugurates Newly-Expanded Drug Product Facility

Edition 2 / June 2022
Small Molecules Platform > CordenPharma Fribourg Inaugurates Expanded Drug Product Manufacturing Facility
June 8, 2022

World Pharma Today: Solid Dose Pharmaceuticals to Remain Strong

June 8, 2022
World Pharma Today Interview: Dr. Brittany Hayes talks trends & strategy of Oral Solid Dose (OSD) manufacturing.
June 1, 2022

Strategic Investment Increases xRNA-based LNP Formulation Services at Caponago Injectable Facility

June 1, 2022
Press Release > CordenPharma Invests in xRNA-based LNP Formulation Services at its Caponago Injectable Facility.
May 2, 2022

Astorg to Acquire Leading Pharmaceutical CDMO CordenPharma from ICIG

May 2, 2022
Press Release > Astorg to Acquire Leading Pharmaceutical CDMO CordenPharma from ICIG.
April 13, 2022

CordenPharma Receives Supplier Recognition Award from Esperion

April 13, 2022
CordenPharma Receives Supplier Recognition Award from Esperion at DCAT Week 2022.
April 11, 2022

CordenPharma and WACKER To Produce mRNA Vaccines for Germany When Needed

April 11, 2022
Press Release > Wacker & CordenPharma win contract to be stand-by ready to produce mRNA vaccines for German government if needed.
March 14, 2022

CEO Discusses CDMO Capex Growth & Expansion in 2022

Edition 1 / March 2022
CEO Editorial > 2022 & Beyond: Resiliency, Expansion & Growth
March 14, 2022

Corden Connect Interviews New Managing Director Yvan Liard of CordenPharma Fribourg

Edition 1 / March 2022
New Facility Acquisition Video Series > Part 1: Interview with Managing Director Yvan Liard of CordenPharma Fribourg
March 14, 2022

Three New Drug Product Facilities Expand Small Molecules Platform

Edition 1 / March 2022
Small Molecules Platform > Three New Drug Product Facilities Expand & Augment Our Small Molecules Platform
March 14, 2022

LNP Formulation Process Capability Expansion in Caponago

Edition 1 / March 2022
Lipid & Injectable Platforms > New Lipid NanoParticle Formulation Capabilities Bring Flexible Drug Development Options
March 10, 2022

CordenPharma Donates to Support Disaster Relief Efforts in the Ukraine

March 10, 2022
CordenPharma donates a combined €100,000 to support disaster relief efforts in the Ukraine.
March 3, 2022

CEO Michael Quirmbach Talks Expanded Footprint, Green Chemistry & Growth

March 3, 2022
Global Business Reports Interview: CEO Michael Quirmbach Talks 2022 Expanded Footprint & Growth Strategy